Stockreport

IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments [Yahoo! Finance]

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF VICTORIA, British Columbia, March 20, 2024 BUSINESS WIRE )--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-drive [Read more]